[1]
Nanau, R.M. and Neuman, M.G. 2014. Safety of Anti-Tumor Necrosis Factor Therapies in Arthritis Patients. Journal of Pharmacy & Pharmaceutical Sciences. 17, 3 (Jul. 2014), 324–361. DOI:https://doi.org/10.18433/J3WP4F.